Author

Shlomo L Maayan

Observed names: Maayan S, Maayan, Shlomo, S MAAYAN, S MAYAN, S Maayan, S. MAAYAN, S. Maayan, SHLOMO MAAYAN, SL Maayan, Shlomo L. Maayan, Shlomo Ma'ayan, Shlomo Maayan, Shlomo Mayaan, Shlomo Mayan

Institution: Barzilai Medical Center

Observed institutions: Ben-Gurion University of the Negev, Bronx-Lebanon Hospital Center, Albert Einstein College of Medicine, New York Medical College, Hebrew University of Jerusalem, Istituto Superiore di Sanità, Emek Medical Center, Metropolitan Hospital Center, Tel Aviv Sourasky Medical Center, Hadassah Medical Center, Kaplan Medical Center, Jacobi Medical Center, Magen David Adom, Barzilai Medical Center, Duke Medical Center, Israel Defense Forces Medical Corps, Tikur Anbessa Hospital, Rosetta Genomics (Israel)

OpenAlex ID: A5107841940

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

2018 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet Infectious Diseases · 408

PDF

Treatment of Intestinal Worms Is Associated With Decreased HIV Plasma Viral Load

2002 · Dawit Wolday, Shlomo Mayaan, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 142

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

2002 · Hugues Loemba, Bluma Brenner, et al. · Antimicrobial Agents and Chemotherapy · 131

Central nervous system involvement in patients with acquired immune deficiency syndrome (AIDS)

2009 · Barbara S. Koppel, Gary P. Wormser, et al. · Acta Neurologica Scandinavica · 124

Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir

2004 · Zehava Grossman, Ellen E. Paxinos, et al. · Antimicrobial Agents and Chemotherapy · 119

Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

2020 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet HIV · 98

Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome

1987 · Shlomo Maayan, Gary P. Wormser, et al. · The American Journal of Medicine · 97

Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B

2001 · Zehava Grossman, Nurit Vardinon, et al. · AIDS · 92

Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to Therapy

2005 · Alessandro Cozzi-Lepri, Lidia Ruiz, et al. · Antiviral Therapy · 69

PDF

Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia

2007 · Woldaregay Erku Abegaz, Zehava Grossman, et al. · Antiviral Therapy · 60

PDF

Acquired Immunodeficiency Syndrome (AIDS) in an Economically Disadvantaged Population

1985 · S. Maayan · Archives of Internal Medicine · 58

Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel

2022 · Matan J. Cohen, Yonatan Oster, et al. · JAMA Network Open · 51

Response to Antiretroviral Therapy among Patients Exposed to Three Classes of Antiretrovirals: Results from the Eurosida Study

2002 · A Mocroft, AN Phillips, et al. · Antiviral Therapy · 45

PDF

HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia

2018 · Dawit Wolday, Muluken Derese, et al. · Infectious Agents and Cancer · 44

PDF

Diffusely Disseminated Cutaneous Leishmania Major Infection in a Child With Acquired Immunodeficiency Syndrome

1995 · David Gillis, Sidney Klaus, et al. · The Pediatric Infectious Disease Journal · 42

Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021–20221

2023 · Roni Biran, Regev Cohen, et al. · Emerging infectious diseases · 40

Men Who Have Sex With Men, Risk Behavior, and HIV Infection: Integrative Analysis of Clinical, Epidemiological, and Laboratory Databases

2011 · I. Levy, Z. Mor, et al. · Clinical Infectious Diseases · 39

Nucleotide and Amino Acid Polymorphisms at Drug Resistance Sites in Non-B-Subtype Variants of Human Immunodeficiency Virus Type 1

2004 · Dan Turner, Bluma Brenner, et al. · Antimicrobial Agents and Chemotherapy · 39

Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients

1986 · F.P. Duncanson, D. Hewlett, et al. · Tubercle · 39

Decline in Esophageal Candidiasis and Use of Antimycotics in European Patients with HIV

2005 · Amanda Mocroft, Cristina Oancea, et al. · The American Journal of Gastroenterology · 36

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial

2011 · G. Fatkenheuer, G. Fatkenheuer, et al. · Journal of Antimicrobial Chemotherapy · 33

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

2016 · Helen Kovari, Caroline A. Sabin, et al. · Open Forum Infectious Diseases · 30

PDF

Drug-Resistant HIV Infection among Drug-Naive Patients in Israel

2004 · Z. Grossman, M. Lorber, et al. · Clinical Infectious Diseases · 30

Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection?

2005 · Amanda Mocroft, Jurgen Rockstroh, et al. · Antiviral Therapy · 29

PDF

Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz

2013 · A. M. Geretti, T. Conibear, et al. · Journal of Antimicrobial Chemotherapy · 26

Works count: 135

Citation count: 2,780

H-index: 26

I10-index: 64